- Home
- PACS vs APGE Comparison
PACS vs APGE Comparison
Compare PACS & APGE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PACS
- APGE
- Stock Information
- Founded
- PACS 2013
- APGE 2022
- Country
- PACS United States
- APGE United States
- Employees
- PACS N/A
- APGE N/A
- Industry
- PACS
- APGE Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- PACS
- APGE Health Care
- Exchange
- PACS Nasdaq
- APGE Nasdaq
- Market Cap
- PACS 1.8B
- APGE 1.8B
- IPO Year
- PACS 2024
- APGE 2023
- Fundamental
- Price
- PACS $10.84
- APGE $35.61
- Analyst Decision
- PACS Strong Buy
- APGE Strong Buy
- Analyst Count
- PACS 9
- APGE 4
- Target Price
- PACS $33.22
- APGE $91.33
- AVG Volume (30 Days)
- PACS 428.3K
- APGE 745.2K
- Earning Date
- PACS 05-16-2025
- APGE 03-03-2025
- Dividend Yield
- PACS N/A
- APGE N/A
- EPS Growth
- PACS 82.80
- APGE N/A
- EPS
- PACS 0.68
- APGE N/A
- Revenue
- PACS $3,558,953,000.00
- APGE N/A
- Revenue This Year
- PACS $30.45
- APGE N/A
- Revenue Next Year
- PACS $16.80
- APGE $795.25
- P/E Ratio
- PACS $15.94
- APGE N/A
- Revenue Growth
- PACS 205.08
- APGE N/A
- 52 Week Low
- PACS $10.61
- APGE $29.10
- 52 Week High
- PACS $43.92
- APGE $66.80
- Technical
- Relative Strength Index (RSI)
- PACS N/A
- APGE 41.65
- Support Level
- PACS N/A
- APGE $38.18
- Resistance Level
- PACS N/A
- APGE $41.07
- Average True Range (ATR)
- PACS 0.00
- APGE 2.13
- MACD
- PACS 0.00
- APGE -0.26
- Stochastic Oscillator
- PACS 0.00
- APGE 5.87
About PACS PACS Group Inc. Common Stock
PACS Group Inc is a post-acute healthcare company primarily focused on delivering high-quality skilled nursing care through a portfolio of independently operated facilities Its is a nursing providers in the United States based on number of facilities, with over 200 post-acute care facilities across nine states serving over 20,000 patients daily. It also provide senior care, assisted living, and independent living options in some of communities.
About APGE Apogee Therapeutics Inc.
Apogee Therapeutics Inc is a biotechnology company seeking to develop differentiated biologics for the treatment of atopic dermatitis (AD), chronic obstructive pulmonary disease (COPD) and related inflammatory and immunology (I&I) indications with high unmet need. Its antibody programs are designed to overcome the limitations of existing therapies by targeting well-established mechanisms of action and incorporating advanced antibody engineering to optimize half-life and other properties. Its two programs are APG777 and APG808, which initially develop for treating AD and COPD, respectively.